Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Partial Onset Seizures”

192 trials

Showing 20 of 192 results

Large-scale testing (Phase 3)Study completedNCT00160615
What this trial is testing

Follow-up Study of L059 (Levetiracetam) in Epileptic Patients With Partial Onset Seizures by Open Label Method

Who this might be right for
Epilepsy, Partial
UCB Japan Co. Ltd. 154
Not applicableNo Longer AvailableNCT01871233
What this trial is testing

An Extended Access Program for Perampanel

Who this might be right for
Partial Onset Seizures
Eisai Inc.
Not applicableStudy completedNCT01620840
What this trial is testing

Lacosamid-i.v.-Register

Who this might be right for
Epilepsy With Partial Onset Seizures With or Without Secondary Generalization
University Hospital Schleswig-Holstein 130
Testing effectiveness (Phase 2)Study completedNCT02150213
What this trial is testing

Medical Safety Follow-up Study for Patients Who Received More Than 28 Days of Total Exposure to BGG492

Who this might be right for
Adrenocortical AdenomaEndometrial Stromal Sarcomas
Novartis Pharmaceuticals 59
Early research (Phase 1)Study completedNCT00426673
What this trial is testing

An Open-Label Interaction Study to Look at the Effects of Brivaracetam on Phenytoin When Taken Together in 15 Adult Patients With Epilepsy.

Who this might be right for
Epilepsy
UCB Pharma 15
Large-scale testing (Phase 3)Study completedNCT00230698
What this trial is testing

The Effectiveness and Safety of Topiramate Monotherapy in Patients With Recently Diagnosed Partial-Onset Seizure

Who this might be right for
EpilepsyEpilepsies, PartialSeizures
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 451
Not applicableStudy completedNCT03082222
What this trial is testing

ZEDEBAC: Zebinix Effects in Dependency of Baseline Conditions

Who this might be right for
Focal Epilepsy
Eisai GmbH 246
Large-scale testing (Phase 3)Study completedNCT00464269
What this trial is testing

Double-blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

Who this might be right for
Epilepsy
UCB Pharma 400
Post-approval studies (Phase 4)WithdrawnNCT02220972
What this trial is testing

To Evaluate the Effect of Perampanel on Objective and Subjective Sleep in Subjects With Insomnia and Partial Onset Seizures

Who this might be right for
Epilepsy, Partial
Eisai Inc.
Testing effectiveness (Phase 2)Study completedNCT00938431
What this trial is testing

A Multicenter, Open-Label Study To Investigate The Safety And Pharmacokinetics Of Lacosamide In Children With Partial Seizures

Who this might be right for
Epilepsy
UCB Pharma 47
Post-approval studies (Phase 4)Study completedNCT01630057
What this trial is testing

Evaluation of the Efficacy and Safety of Adjunctive Zonisamide vs Replacement With Zonisamide of the Last Added Antiepileptic Drug

Who this might be right for
Partial Seizures
Eisai Inc. 200
Post-approval studies (Phase 4)Study completedNCT00215592
What this trial is testing

Open Label, Zonegran (Zonisamide) In Partial Onset Seizures

Who this might be right for
Epilepsy
Eisai Limited 1,000
Large-scale testing (Phase 3)Study completedNCT00504881
What this trial is testing

Brivaracetam as add-on Treatment in Adolescents and Adults Suffering From Epilepsy

Who this might be right for
Epilepsy
UCB Pharma SA 480
Large-scale testing (Phase 3)Study completedNCT01618695
What this trial is testing

A Study With an Open-label Extension Phase to Evaluate the Efficacy and Safety of Perampanel (E2007) Administered as an Adjunctive Therapy in Subjects With Refractory Partial-onset Seizures

Who this might be right for
Partial-onset Seizures
Eisai Co., Ltd. 940
Large-scale testing (Phase 3)Study completedNCT01262677
What this trial is testing

Once-A-Day Pregabalin For Partial Seizures

Who this might be right for
Partial SeizuresEpilepsies, Partial
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 325
Post-approval studies (Phase 4)Study completedNCT03116828
What this trial is testing

A Drug to be Used in Addition With Another Drug to Treat Adults With Uncontrolled Partial-onset Seizures

Who this might be right for
Epilepsy With Partial On-set Seizures
Sumitomo Pharma America, Inc. 102
Large-scale testing (Phase 3)WithdrawnNCT03108729
What this trial is testing

A Pediatric Drug Study to Determine the Long-term Safety and Tolerability in Children and Adolescents (4-17 Years in Age) Taking the Drug

Who this might be right for
Epilepsy
Sumitomo Pharma America, Inc.
Large-scale testing (Phase 3)Study completedNCT00236743
What this trial is testing

The Effectiveness and Safety of Topiramate in the Treatment of Children With Epilepsy

Who this might be right for
EpilepsyEpilepsies, PartialSeizures
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 90
Large-scale testing (Phase 3)Ended earlyNCT00697762
What this trial is testing

Effectiveness and Safety Study for RWJ-333369 as Adjunctive Therapy in Korean and Japanese Patients With Partial Onset Seizures

Who this might be right for
Seizures
SK Life Science, Inc. 56
Testing effectiveness (Phase 2)Study completedNCT00105040
What this trial is testing

A 19-week Cognition Study of Levetiracetam in Children With Partial Onset Seizures

Who this might be right for
Epilepsy, Partial
UCB Pharma 87
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation